Transfusion

Cover image for Vol. 53 Issue 5

May 2013

Volume 53, Issue 5

Pages 925–1147

  1. In This Issue

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. In this issue (page 925)

      Article first published online: 9 MAY 2013 | DOI: 10.1111/j.1537-2995.2013.03874.x

  2. EDITORIALS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Antibodies of undetermined significance: nuisance or near miss? (pages 926–928)

      Christopher A. Tormey and Jeanne E. Hendrickson

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12147

    2. Single-page reports of new alleles or antigens (page 929)

      Connie M. Westhoff and Paul M. Ness

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12210

  3. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. The original Leukotrap (page 930)

      Phandee Watanaboonyongcharoen, Yara A. Park and Mark E. Brecher

      Article first published online: 9 MAY 2013 | DOI: 10.1111/j.1537-2995.2012.03929.x

  4. IMMUNOHEMATOLOGY

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother–child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation (pages 939–947)

      Esther P. Verduin, Henk Schonewille, Anneke Brand, Geert W. Haasnoot, Frans H.J. Claas, Irene T.M. Lindenburg, Enrico Lopriore, Dick Oepkes, Dave L. Roelen and Ilias I.N. Doxiadis

      Article first published online: 23 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03862.x

  5. BLOOD MANAGEMENT

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Eight-year experience of bloodless surgery at a tertiary care hospital in Korea (pages 948–954)

      Kyung Il Jo, Jeong Won Shin, Tae Yoon Choi, Yu Jin Park, Wook Youm and Moon Jung Kim

      Article first published online: 23 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03859.x

  6. BLOOD GROUP GENOMICS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. RHCE*cE734C allele encodes an altered c antigen and a suppressed E antigen not detected with standard reagents (pages 955–961)

      Monique Silvy, Aurélie Barrault, Randall W. Velliquette, Christine Lomas-Francis, Sophie Simon, Rosanna Mortelecque, Jacques Chiaroni, Philippe Bierling, France Noizat-Pirenne, Pascal Bailly and Christophe Tournamille

      Article first published online: 7 SEP 2012 | DOI: 10.1111/j.1537-2995.2012.03860.x

    2. A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants (pages 962–971)

      Kate Hsu, Yen-Chun Lin, Yu-Cheng Chang, Yung-Syu Chan, Hsueh-Ping Chao, Ting-Ying Lee and Marie Lin

      Article first published online: 23 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03861.x

  7. BLOOD COMPONENTS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution (pages 972–980)

      Larry J. Dumont, Jose A. Cancelas, Sharon Graminske, Kenneth D. Friedman, Ralph R. Vassallo, Pamela H. Whitley, Neeta Rugg, Deborah F. Dumont, Louise Herschel, Alan H. Siegal, Zbigniew M. Szczepiorkowski, Logan Fender and Anna Razatos

      Article first published online: 6 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03841.x

    2. Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis (pages 981–989)

      Tamir Kanias, Ling Wang, Ashley Lippert, Daniel B. Kim-Shapiro and Mark T. Gladwin

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03850.x

    3. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets (pages 990–1000)

      Saber Bashir, Philip Cookson, Michael Wiltshire, Louise Hawkins, Luke Sonoda, Stephen Thomas, Axel Seltsam, Frank Tolksdorf, Lorna M. Williamson and Rebecca Cardigan

      Article first published online: 21 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03854.x

    4. Washing of banked blood by three different blood salvage devices (pages 1001–1009)

      Michael Gruber, Anita Breu, Melanie Frauendorf, Timo Seyfried and Ernil Hansen

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03853.x

    5. Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products (pages 1010–1018)

      Eike Steinmann, Ute Gravemann, Martina Friesland, Juliane Doerrbecker, Thomas H. Müller, Thomas Pietschmann and Axel Seltsam

      Article first published online: 21 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03858.x

  8. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation (pages 1019–1023)

      Lilach Bonstein, Galia Stemer, Eldad J. Dann, Tsila Zuckerman, Riva Fineman and Nuhad Haddad

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03855.x

    2. CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients (pages 1024–1032)

      Ville Varmavuo, Pentti Mäntymaa, Raija Silvennoinen, Tapio Nousiainen, Taru Kuittinen and Esa Jantunen

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03848.x

  9. IMMUNE HEMATOLOGIC DISEASE

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. The first example of a patient with etoricoxib-induced immune hemolytic anemia (pages 1033–1036)

      Beate Mayer, Ramona Genth, Rainer Dehner and Abdulgabar Salama

      Article first published online: 6 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03843.x

  10. HEMATOPOIESIS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. SALL4 is a key transcription regulator in normal human hematopoiesis (pages 1037–1049)

      Chong Gao, Nikki R. Kong, Ailing Li, Hiro Tatetu, Shikiko Ueno, Youyang Yang, Jie He, Jianchang Yang, Yupo Ma, Grace S. Kao, Daniel G. Tenen and Li Chai

      Article first published online: 30 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03888.x

  11. TRANSFUSION PRACTICE

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study (pages 1050–1058)

      Simon J. Stanworth, Timothy S. Walsh, Robin J. Prescott, Robert J. Lee, Douglas M. Watson, Duncan L.A. Wyncoll and Intensive Care Study of Coagulopathy (ISOC) investigators

      Article first published online: 28 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03866.x

    2. Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion (pages 1059–1068)

      Jon A. Detterich, Suvimol Sangkatumvong, Roberta Kato, Ani Dongelyan, Adam Bush, Michael Khoo, Herbert J. Meiselman, Thomas D. Coates and John C. Wood

      Article first published online: 26 NOV 2012 | DOI: 10.1111/j.1537-2995.2012.03961.x

    3. Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom (pages 1069–1076)

      Vipul Jairath, Brennan C. Kahan, Simon J. Stanworth, Richard F.A. Logan, Sarah A. Hearnshaw, Simon P.L. Travis, Kelvin R. Palmer and Michael F. Murphy

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03849.x

    4. The role of failure modes and effects analysis in showing the benefits of automation in the blood bank (pages 1077–1082)

      Tae Hee Han, Moon Jung Kim, Shinyoung Kim, Hyun Ok Kim, Mi Ae Lee, Ji Seon Choi, Mina Hur and Andrew St John

      Article first published online: 25 SEP 2012 | DOI: 10.1111/j.1537-2995.2012.03883.x

  12. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center (pages 1083–1087)

      Debra A. Kessler, Patricia A. Shi, Scott T. Avecilla and Beth H. Shaz

      Article first published online: 15 AUG 2012 | DOI: 10.1111/j.1537-2995.2012.03856.x

    2. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections (pages 1088–1094)

      Malte Ziemann, Hans-Gert Heuft, Kerstin Frank, Sabine Kraas, Siegfried Görg and Holger Hennig

      Article first published online: 16 JAN 2013 | DOI: 10.1111/trf.12074

  13. HEMAPHERESIS

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
  14. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment (pages 1108–1119)

      Kathleen L. Bagot, Liliana L. Bove, Barbara M. Masser, Timothy C. Bednall and Mark Buzza

      Article first published online: 24 SEP 2012 | DOI: 10.1111/j.1537-2995.2012.03891.x

  15. REVIEW

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
  16. COMMENTARY

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
  17. LETTERS TO THE EDITOR

    1. Top of page
    2. In This Issue
    3. EDITORIALS
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. IMMUNOHEMATOLOGY
    6. BLOOD MANAGEMENT
    7. BLOOD GROUP GENOMICS
    8. BLOOD COMPONENTS
    9. TRANSPLANTATION AND CELLULAR ENGINEERING
    10. IMMUNE HEMATOLOGIC DISEASE
    11. HEMATOPOIESIS
    12. TRANSFUSION PRACTICE
    13. TRANSFUSION COMPLICATIONS
    14. HEMAPHERESIS
    15. BLOOD DONORS AND BLOOD COLLECTION
    16. REVIEW
    17. COMMENTARY
    18. LETTERS TO THE EDITOR
    1. Therapy with fibrinogen concentrate: clinical and ethical considerations (pages 1137–1138)

      Benno von Bormann, Sirilak Suksompong and Rolf Zander

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12113

    2. In reply (pages 1138–1140)

      Cristina Solomon and Niels Rahe-Meyer

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12163

    3. Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates (pages 1143–1144)

      J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Christine De Staercke, Michael Recht, Meera B. Chitlur, Ralph Gruppo, W. Craig Hooper, Craig Kessler, Marilyn J. Manco-Johnson, Jerry Powell, Meredith Pyle, Brenda Riske, Hernan Sabio and Sean Trimble

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12153

    4. Intermittent leukocytosis in an asymptomatic platelet donor (pages 1144–1146)

      Sandhya R. Panch, Monica M. Riordan, Susan J. Miranda and Susan F. Leitman

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12155

    5. Systemic hypersensitivity reaction mimicking anaphylaxis after first filgrastim administration in a healthy donor (pages 1146–1147)

      Ashok Tholpady, Ion Chiosea, Jonathan J. Lyons, Kristin Baird and Susan F. Leitman

      Article first published online: 9 MAY 2013 | DOI: 10.1111/trf.12149

SEARCH

SEARCH BY CITATION